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A B S T R A C T
Background
Acute upper respiratory tract infections (URTIs) are frequently managed in primary care settings. Although many are viral, and there
is an increasing problem with antibiotic resistance, antibiotics continue to be prescribed for URTIs. Written patient information may
be a simple way to reduce antibiotic use for acute URTIs.
Objectives
To assess if written information for patients (or parents of child patients) reduces the use of antibiotics for acute URTIs in primary care.
Search methods
We searched CENTRAL, MEDLINE, Embase, CINAHL, LILACS, Web of Science, clinical trials.gov, and the World Health Orga-
nization (WHO) trials registry up to July 2016 without language or publication restrictions.
Selection criteria
We included randomised controlled trials (RCTs) involving patients (or parents of child patients) with acute URTIs, that compared
written patient information delivered immediately before or during prescribing, with no information. RCTs needed to have measured
our primary outcome (antibiotic use) to be included.
Data collection and analysis
Two review authors screened studies, extracted data, and assessed study quality. We could not meta-analyse included studies due to
significant methodological and statistical heterogeneity; we summarised the data narratively.
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Main results
Two RCTs met our inclusion criteria, involving a total of 827 participants. Both studies only recruited children with acute URTIs
(adults were not involved in either study): 558 children from 61 general practices in England and Wales; and 269 primary care doctors
who provided data on 33,792 patient-doctor consultations in Kentucky, USA. The UK study had a high risk of bias due to lack of
blinding and the US cluster-randomised study had a high risk of bias because the methods to allocate participants to treatment groups
was not clear, and there was evidence of baseline imbalance.
In both studies, clinicians provided written information to parents of child patients during primary care consultations: one trained
general practitioners (GPs) to discuss an eight-page booklet with parents; the other conducted a factorial trial with two comparison
groups (written information compared to usual care and written information plus prescribing feedback to clinicians compared to
prescribing feedback alone). Doctors in the written information arms received 25 copies of two-page government-sponsored pamphlets
to distribute to parents.
Compared to usual care, we found moderate quality evidence (one study) that written information significantly reduced the number
of antibiotics used by patients (RR 0.53, 95% CI 0.35 to 0.80; absolute risk reduction (ARR) 20% (22% versus 42%)) and had no
significant effect on reconsultation rates (RR 0.79, 95% CI 0.47 to 1.32), or parent satisfaction with consultation (RR 0.95, 95%
CI 0.87 to 1.03). Low quality evidence (two studies) demonstrated that written information also reduced antibiotics prescribed by
clinicians (RR 0.47, 95% CI 0.28 to 0.78; ARR 21% (20% versus 41%); and RR 0.84, 95% CI 0.81 to 0.86; 9% ARR (45% versus
54%)). Neither study measured resolution of symptoms, patient knowledge about antibiotics for acute URTIs, or complications for
this comparison.
Compared to prescribing feedback, we found low quality evidence that written information plus prescribing feedback significantly
increased the number of antibiotics prescribed by clinicians (RR 1.13, 95% CI 1.09 to 1.17; absolute risk increase 6% (50% versus
44%)). Neither study measured reconsultation rate, resolution of symptoms, patient knowledge about antibiotics for acute URTIs,
patient satisfaction with consultation or complications for this comparison.
Authors’ conclusions
Compared to usual care, moderate quality evidence from one study showed that trained GPs providing written information to parents
of children with acute URTIs in primary care can reduce the number of antibiotics used by patients without any negative impact on
reconsultation rates or parental satisfaction with consultation. Low quality evidence from two studies shows that, compared to usual
care, GPs prescribe fewer antibiotics for acute URTIs but prescribe more antibiotics when written information is provided alongside
prescribing feedback (compared to prescribing feedback alone). There was no evidence addressing resolution of patients’ symptoms,
patient knowledge about antibiotics for acute URTIs, or frequency of complications.
To fill evidence gaps, future studies should consider testing written information on antibiotic use for adults with acute URTIs in high-
and low-income settings provided without clinician training and presented in different formats (such as electronic). Future study designs
should endeavour to ensure blinded outcome assessors. Study aims should include measurement of the effect of written information on
the number of antibiotics used by patients and prescribed by clinicians, patient satisfaction, reconsultation, patients’ knowledge about
antibiotics, resolution of symptoms, and complications.
P L A I N L A N G U A G E S U M M A R Y
Does written information reduce antibiotic use for upper airway infections among people treated in primary care settings?
Review question
We wanted to find out if written information reduces antibiotic use for acute upper airway infections (colds, sore throats, cough, or
earaches).
Background
Most colds, sore throats, coughs and earaches are caused by viruses. Although antibiotics do not work against viruses, they are sometimes
prescribed. We wanted to find out if giving written information about antibiotics immediately before or during doctor visits, together
with usual care, changed antibiotic use compared with the doctor’s usual practice or something else. We also wanted to know if: patients
would be more likely to return to their doctor; symptoms would improve sooner; patients’ knowledge about antibiotics would improve;
patients were satisfied with their doctor’s care; and if complications occurred.
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Search date
We searched the literature up to July 2016.
Study characteristics
We found two studies that included children with upper airway infections: one involved 558 children who were recruited from 61
general practices in England and Wales; and another of 269 doctors who provided data on 33,792 patient-doctor consultations in
Kentucky, USA. Participants were children accompanied by an adult. One study trained general practitioners (GPs) to discuss written
information with parents, and in the other, doctors distributed copies of government-sponsored pamphlets to parents.
Study funding sources
Both studies were funded by government bodies and one was also funded by Pfizer (a pharmaceutical company).
Key results
Providing a booklet and explanation by a specially-trained doctor reduced the number of antibiotics children consumed by 20% (from
42% to 22%) without affecting parent satisfaction with consultation or numbers of return visits for the same illness. Compared to
the doctor’s usual practice, two studies showed that providing a booklet reduced the proportion of children prescribed an antibiotic
by 9% to 21%. When doctors were also given feedback on their antibiotic prescribing along with providing a booklet to parents, the
proportion of children prescribed an antibiotic increased by 6% (from 44% to 50%). None of the included studies assessed if people
were better informed, how long symptoms lasted, or if people had complications.
Quality of evidence
Evidence quality was moderate to low. Doctors and parents knew when written information had been used. One study had a high risk
of bias because study groups were not comparable at baseline, so we can be less confident of its findings.
Studies were set in the UK and USA, so results are not applicable to lower-income countries, nor for different primary healthcare
services, including settings where prescriptions are unnecessary to obtain antibiotics.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Writ ten information for pat ients (or parents of child pat ients) compared with usual care to reduce the use of ant ibiot ics for acute upper respiratory tract infect ions in primary
care
Patient or population: pat ients (or parents of child pat ients) with acute upper respiratory tract infect ions
Setting: primary care
Intervention: writ ten information on ant ibiot ics
Comparison: usual care
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Usual care Written information
Antibiot ics used by pat ients 420 per 1000 222 per 1000
(147 to 336)
RR 0.53
(0.35 to 0.80)
2201
(1 RCT)
⊕⊕⊕©
moderate2,3
Antibiot ics prescribed by
clinicians
407 per 1000 190 per 1000
(114 to 317)
RR 0.47 (0.28 to 0.78) 18,8131
(2 RCTs)
⊕⊕©©
low4,5,6,7
539 per 1000 453 per 1000
(437 to 464)
RR 0.84 (0.81 to 0.86)
Reconsultat ion rates 164 per 1000 129 per 1000
(77 to 216)
RR 0.79
(0.47 to 1.32)
3471
(1 RCT)
⊕⊕⊕©
moderate2,3
Patient sat isfact ion with
consultat ion
938 per 1000 891 per 1000
(816 to 966)
RR 0.95
(0.87 to 1.03)
2201
(1 RCT)
⊕⊕⊕©
moderate2,3
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: conf idence interval; RCT : randomised controlled trial; RR: risk rat io.
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GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Sample size for Francis 2009 was 558. This sample size was adjusted for clustering: intraclass correlat ion coef f icient
(ICC) 0.15 for ant ibiot ics used by pat ients and pat ient sat isfact ion, 0.24 for ant ibiot ics prescribed by clinicians, 0.06 for
reconsultat ion. Sample size for Mainous 2000 was 33,792 pat ient-doctor consultat ions.
2 Downgraded due to risk of bias. High risk of bias for performance and detect ion bias - part icipants and personnel were
unblinded, and outcome was measured by self -report .
3Downgraded due to indirectness. Study only included children with acute URTIs, and general pract it ioners (GPs) were trained
to explain the intervent ion to parents. The ef fect of using writ ten information with adults or delivering it without an explanat ion
is not known.
4 Downgraded due to imprecision. Francis 2009 was a small study with wide conf idence intervals. Mainous 2000 was a larger
study with narrow conf idence intervals.
5 Downgraded due to indirectness. Both studies included children with acute URTIs and provided either training or a letter
to clinicians. The ef fect of using writ ten information with adults and delivering it without addit ional training or a letter to
clinicians is not known.
6 Downgraded due to inconsistency. Signif icant heterogeneity between studies that precluded pooling of data.
7 Downgraded due to risk of bias. High risk of bias across studies for all domains of risk of bias.
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B A C K G R O U N D
Description of the condition
Respiratory infections are a heterogeneous group of diseases that
are traditionally divided into upper respiratory tract infections
(URTIs) or lower respiratory tract infections (LRTIs). These in-
fections are typically defined as above or below the vocal folds, re-
spectively. URTIs can include acute rhinitis (common cold), acute
otitis media (AOM), sore throat, acute cough, and influenza. They
are commonly caused by viruses and usually present with nasal
stuffiness and discharge, sneezing, sore throat, and cough. Other
symptoms include hoarseness, headache, malaise, and lethargy
(Heikkinen 2003). Viral transmission is via contact with bodily se-
cretions or, less commonly, air transmission (via particle aerosols)
(Heikkinen 2003). On average, children are subject to six to eight
URTIs per year; and two to four per year among adults (Heikkinen
2003). In the USA, more than 70% of outpatients with an URTI
will receive an antibiotic (Lee 2014). Growing evidence suggests
that antibiotics have little or no effect on URTIs: common cold
(Kenealy 2013), AOM (Venekamp 2015), pharyngitis (Spinks
2013), and acute laryngitis (Reveiz 2015). They may also cause
rash, abdominal pain, diarrhoea, and vomiting. On a global and
individual level, antibiotic use is associated with the development
of antibiotic resistance (Costelloe 2010; Goossens 2005). But an-
tibiotic resistance could be reversed - resistance in commensals de-
creases rapidly to near pre-antibiotic levels within 12 months of
last antibiotic use (Costelloe 2010).
Description of the intervention
Written information on the use of antibiotics potentially offers a
cheap and practical method of reducing antibiotic use for people
with acute URTIs. This approach can be used either in isolation,
or combined with other interventions, such as delayed prescrib-
ing (where patients are asked to wait a few days before using an-
tibiotics) (Spurling 2013), shared decision-making (Légaré 2012),
and behavioural interventions (Meeker 2014).
How the intervention might work
Knowledge of illness and treatment, beliefs about the bene-
fits or harms of taking a treatment, and expectations of treat-
ment outcome are known to influence medication-taking be-
haviour (Jackson 2014; Michie 2011). Patients consistently over-
estimate the benefits of treatment and underestimate their harms
(Hoffmann 2014).Written information about antibiotics for acute
URTIs may target these determinants of antibiotic-taking be-
haviour and thereby, change patients’ antibiotic use. In the case
of children, written information may change parents’ decisions to
use antibiotics for their children. Patients who receive antibiotics
to treat acute URTIs are more likely to attend repeat consultations
with the same illness (Moore 2009). Providing written informa-
tion may also change clinician behaviour, by providing a tool that
clinicians can use to initiate discussions about the benefits and
harms of antibiotics for URTI. If written information was able to
prevent patients taking antibiotics, this would potentially inter-
rupt this cycle, reduce repeat consultation rates, and subsequent
antibiotic use.
Why it is important to do this review
Antibiotic resistance is a major global health problem that is pre-
dicted to cause 10 million deaths annually and cost USD 100 tril-
lion by 2050 (Review on Antimicrobial Resistance 2014). Global
antibiotic use continues to grow (Van Boeckel 2014), despite
most clinicians being aware of the growing antibiotic resistance
problem (McCullough 2015). Many different approaches to re-
ducing antibiotic use in primary care have been tested (Arnold
2005), and several have been shown to be effective (Plejdrup
Hansen 2015), including: delayed prescribing (Spurling 2013);
shared decision-making (Légaré 2012); and behavioural interven-
tions (Meeker 2014). However, many of these interventions re-
quire significant changes in clinician and patient behaviour. This
is particularly challenging because many clinicians do not believe
their prescribing patterns contribute to the development of re-
sistance (McCullough 2015). Simple and effective interventions
that target patients’ knowledge and beliefs about antibiotics may
overcome some of these barriers. Identifying whether written in-
formation about antibiotics is effective is particularly important
because it has the potential to be implemented in primary care
settings globally.
O B J E C T I V E S
To assess if written information for patients (or parents of child
patients) reduces the use of antibiotics for acute upper respiratory
tract infections (URTIs) in primary care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included RCTs that compared information about antibiotics
for acute upper respiratory tract infections (URTIs) with no in-
formation. We also included studies that included information as
an add-on intervention.
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Types of participants
Patients of all ages defined as having an acute URTI presenting
to primary care were included. When children were involved, the
intervention may have been directed to the parent/guardian. We
excluded patients with lower respiratory tract infections (LRTIs)
and those with chronic lung conditions, such as chronic obstruc-
tive pulmonary disease. Primary care was defined as general prac-
tice, emergency department (accident and emergency), and other
primary care settings.
Types of interventions
1. Written information versus no written information.
2. Written information plus intervention-X versus no written
information plus intervention-X (for example, where
Intervention-X was delayed prescribing or another intervention).
Any written information, in both paper (e.g. handout, booklet,
poster) or electronic (e.g. video) format, given to a patient with the
aim of informing them about antibiotics for acute URTIs, either as
themain or as an add-on intervention.This informationmust have
been given at the time of prescribing, that is, immediately before
or during a consultation where an antibiotic may be prescribed.
Studies were eligible if patients were or were not about to receive
an antibiotic prescription. Information must have included details
about antibiotics for acuteURTIs, but did not have to be exclusive.
We excluded studies that offered information after prescribing, for
example, pharmacists providing education via package inserts. We
excluded interventions where only verbal information was given.
Types of outcome measures
We extracted outcome data at the end of treatment and end of
follow-up. We excluded studies that did not measure our primary
outcome.
Primary outcomes
1. Antibiotic use (measured as antibiotics used by patients or
antibiotics prescribed by clinicians)
Secondary outcomes
1. Reconsultation rates.
2. Resolution of symptoms.
3. Patient knowledge about antibiotics for acute URTIs.
4. Patient satisfaction with consultation.
5. Complications
i) Adverse drug reaction due to the prescribed
antibiotics.
ii) Disease complications (for example, pneumonia or
mastoiditis).
If future studies were to report time to resolution data we would
add this as a secondary outcome.
Search methods for identification of studies
Electronic searches
We searched CENTRAL (6 July 2016; Issue 6, June 2016), which
contains the Cochrane Acute Respiratory Infections Group’s Spe-
cialisedRegister,MEDLINE (1946 to 6 July 2016), Embase (2010
to 6 July 2016), CINAHL (1981 to 6 July 2016), LILACS (1982
to 6 July 2016), and Web of Science (1955 to 6 July 2016).
We used the search strategy described in Appendix 1 to search
MEDLINEandCENTRAL.We combined theMEDLINEsearch
with the Cochrane Highly Sensitive Search Strategy for iden-
tifying randomised trials in MEDLINE (Lefebvre 2011). We
adapted the search strategy to search Embase (Appendix 2),
CINAHL (Appendix 3), LILACS (Appendix 4), and Web of Sci-
ence (Appendix 5). We did not use any language or publication
restrictions.
Searching other resources
We searched theWHO International Clinical Trials Registry Plat-
form (ICTRP) (www.who.int/ictrp/en; Appendix 6), and Clini-
calTrials.gov (www.clinicaltrials.gov; Appendix 7), for completed
and ongoing studies. We reviewed the reference lists of retrieved
articles.
Data collection and analysis
Selection of studies
Two review authors (JOS, RH or AMcC) independently assessed
abstracts for eligibility and selected studies for full-text review. We
resolved disagreements by discussion with a third review author
(AMcC or PG).
Data extraction and management
Two review authors (JOS, RH) independently extracted data using
a standardised Cochrane data collection form. We extracted the
following information.
1. Age and gender of participants.
2. Number of participants.
3. Literacy level of participants (measured by highest level of
education or other methods employed by authors).
4. Description of intervention content, mode of delivery and
fidelity to intervention, where available.
5. Antibiotic use.
6. Reconsultation rates.
7. Symptom resolution.
8. Complications such as adverse drug reactions and disease
complications.
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One of the included studies provided a copy of their patient in-
formation online, free of charge (www.whenshouldiworry.com)
(Francis 2009). We contacted the other study authors, but they
were unable to provide any of the original data files (Mainous
2000).
Assessment of risk of bias in included studies
Two review authors (JOS or RH) independently assessed the risk
of bias of included studies using the Cochrane ’Risk of bias’ tool
(Higgins 2011). Any disagreements were resolved by consensus.
We assessed the following domains.
Selection bias
The method used to generate allocation sequencing and whether
this method was adequate to produce comparable groups was as-
sessed independently by two review authors.
Two review authors independently assessed the method used to
conceal the allocation sequence to determine whether interven-
tion allocations could have been foreseen in advance of or during
enrolment.
Performance bias
Two review authors independently assessed the measures used to
blind study participants and personnel from knowledge of which
intervention a participant received. Two review authors assessed if
the intended blinding was effective.
Detection bias
Two review authors independently assessed the measures used to
blind outcome assessors from knowledge of which intervention a
participant received. Two review authors assessed if the intended
blinding was effective.
Attrition bias
Two review authors independently assessed the completeness of
outcome data for each main outcome, including attrition and
exclusions from the analysis. Two review authors determined
whether attrition and exclusions were reported, the numbers in
each intervention group (compared to total randomised partici-
pants), reasons for attrition/exclusions (if reported), and any re-
inclusions in analyses (if performed).
Reporting bias
Two review authors independently assessed whether the possibility
of selective outcome reporting was examined by study authors,
and elaborated on what was found.
Other bias
Two review authors independently assessed whether authors stated
any important concerns about bias not addressed. Authors noted
any significant information about sources of funding that may
introduce bias. Two review authors assessed the quality of included
studies.
All review authors resolved any disagreements by consensus. If
required, we were prepared to reconstruct an intention-to-treat
analysis.
Measures of treatment effect
We used Review Manager 5 for data analyses (RevMan 2014).
For dichotomous primary and secondary outcomes, we used risk
ratios (RRs) as the main measure of effect. If studies can be meta-
analysed when updating this review, we will calculate and report
the number needed to treat to benefit (NNTB) for any statistically
significant outcomes.
Unit of analysis issues
Units of randomisation were: general practices (Francis 2009); and
primary care clinicians (Mainous 2000). Units of analysis were:
parents of patients (Francis 2009); and episodes of care (defined
as one patient-clinician consultation with acute URTI as the di-
agnosis) (Mainous 2000). The same parent and child may have
contributed tomore than one episode of care if they attended their
physicianwith anURTImore than once during the data collection
period. We adjusted for within-cluster correlations by calculating
the design effect of included studies using the formula 1 + (M
- 1)*ICC. Where M equals average cluster size and ICC equals
intraclass correlation coefficient. Francis 2009 included a specific
ICC for two outcomes: antibiotics prescribed by clinicians (ICC
0.24) and reconsultation (ICC 0.06). They did not report a spe-
cific ICC for antibiotics used by patients or satisfaction. For these
two outcomes, we calculated the mean ICC from the reported
outcomes, that is, 0.24 + 0.06/2 = 0.15. Cluster sizes (M) averaged
9.5 in the intervention group and 10 in the usual care group. We
divided the sample size for each outcome by the design effect to
calculate the effective sample size. Mainous 2000 did not report
any information on cluster size or ICC so we could not adjust for
clustering in that study.
Dealing with missing data
The included studies had minimal missing data. We emailed
the authors of seven studies to request further or stratified data
(Alder 2005; Bauchner 2001; Mainous 2000; Schnellinger 2010;
Sustersic 2012; Taylor 2003; Taylor 2005). The study authors ei-
ther did not reply or no longer had the data available. If eligible
studies are identified in future updates, we will contact study au-
thors for clarification of any missing data. If a study outcome has
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more than 20% missing data, we will exclude it from the primary
analysis but include it in a sensitivity analysis.
Assessment of heterogeneity
We assessed the presence of heterogeneity by comparing pop-
ulations, settings, interventions, and outcomes before deciding
whether it was appropriate to pool study data using a fixed-effect
analysis, a random-effects analysis, or to not pool data. If appropri-
ate, when updating the review, we will assess statistical heterogene-
ity by means of the I² statistic (Higgins 2011). We will interpret
heterogeneity as outlined in the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011): 0% to 40% -might not be
important; 30% to 60% - may represent moderate heterogeneity;
50% to 90% - may represent substantial heterogeneity; 75% to
100% - considerable heterogeneity.
Assessment of reporting biases
We searched ClinicalTrials.gov and the WHO International
Clinical Trials Registry Platform for unpublished studies (
www.clinicaltrials.gov; www.who.int/ictrp/en). When updating
this review, we will contact study authors to request any unre-
ported outcomes.
Data synthesis
We attempted to meta-analyse data for antibiotics prescribed by
clinicians but concluded that heterogeneity between the included
studies was too great (I² statistic = 80%). Data are presented as a
narrative synthesis. If appropriate when updating this review, we
will analyse differences in antibiotic use using a risk ratio (RR)
with 95% CI calculated by the Mantel-Haenszel method using
a fixed-effect model (where appropriate, based on Assessment of
heterogeneity).
GRADE and ’Summary of findings’ table
We created two ’Summary of findings’ tables that present data for
both comparisons (Summary of findings for themain comparison;
Summary of findings 2). We used the five GRADE considerations
(study limitations, consistency of effect, imprecision, indirectness,
and publication bias) to assess evidence quality for the prespecified
outcomes (GRADEWorkingGroup 2004).We usedmethods and
recommendations described in Section 8.5 and Chapter 12 of the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011), and GRADEproGDT software (GRADEproGDT2014).
We justified all decisions to down- or upgrade the quality of studies
using footnotes, andmade comments to aid readers’ understanding
of the review, where necessary.
Subgroup analysis and investigation of heterogeneity
When updating the review, we will conduct subgroup analysis of
the impact of patient information based on whether or not delayed
prescribing was also used. Factorial studies (2 x 2 of delayed pre-
scription x handout) will contribute to both groups. This princi-
ple would also be used for other potential co-interventions within
studies.
Sensitivity analysis
When updating this review, if a study outcome has more than
20% missing data, we will exclude it from the primary analysis
but include it in a sensitivity analysis (see Dealing with missing
data). We plan to conduct sensitivity analyses to determine the
robustness of results to intervention intensity and fidelity.
R E S U L T S
Description of studies
Results of the search
We retrieved 600 studies for title and abstract screening from six
electronic databases and 127 from reviewing the reference lists
of retrieved studies. After removal of duplicates, we screened 517
titles and abstracts, identified 54 records for full-text review, and
included two studies in the qualitative synthesis (Francis 2009;
Mainous 2000) (Figure 1).
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Figure 1. Study flow diagram
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Included studies
We included two studies that investigated two different written
information interventions (both delivered to parents of child pa-
tients during primary care consultation). Francis 2009 recruited
558 children from 61 general practices in England andWales, and
Mainous 2000 recruited 269 primary care doctors who provided
data on 33,792 patient-doctor consultations in Kentucky, USA.
See Characteristics of included studies.
Study design
Francis 2009 conducted a two-armpragmatic cluster-RCTofwrit-
ten information compared to usual care.Mainous 2000 conducted
a four-arm factorial cluster-RCT and we extracted data on two
comparisons from this study: written information compared to
usual care and written information plus prescribing feedback to
clinicians compared to prescribing feedback to clinicians alone.
Characteristics of settings and participants
Francis 2009 was conducted in 61 general practices (n = 558 pa-
tients) in the United Kingdom; andMainous 2000 was conducted
in the United States with 269 primary care clinicians (family prac-
tice, paediatricians or ’other primary care’). Both included children
with acute upper respiratory tract infections (URTIs). Mainous
2000 reported baseline differences in the number of acute URTI
episodes and the geographical location of the clinicians targeted
(see Characteristics of included studies).
Characteristics of interventions and comparisons
The written information intervention was different in both stud-
ies. Francis 2009 trained general practitioners (GPs) to discuss an
eight-page booklet on acute URTIs during a consultation with
parents. Parents of children in the intervention group received
the booklet during consultation with their GP (When should I
worry). Fidelity to the intervention was not assessed because the
authors wanted telephone assessors to remain blinded. GPs in the
intervention group underwent online training on how to use the
booklet. Training sessions lasted 40 minutes and included: audio,
video, pictures, and links to further study material; description of
the booklet content; and how to use communication skills to ex-
plore parents’ concerns and expectations. Researchers monitored
GPs’ compliance with the online training via the study website.
Both the booklet and GPs’ training had a theoretical basis in So-
cial Cognitive Theory (Bandura 1996) and the Theory of Planned
Behaviour (Ajzen 1991). GPs randomised to the usual care group
practiced usual care. The authors determined outcomes by tele-
phone questionnaire 14 days after recruitment included: recon-
sultation within two weeks for the same illness (yes or no); antibi-
otics prescribed by the clinician (defined as antibiotics prescribed
at initial consultation or at any time over the following two-week
period); antibiotic use by the patient (self-reported ingestion of
antibiotics over the same time period, including any further antibi-
otics prescribed); and parent satisfaction with the consultation (di-
chotomised to ’very satisfied’ or ’satisfied’ versus ’neutral’, ’dissatis-
fied’ or ’very dissatisfied’). The study authors also measured future
consultation intentions, reassurance, and enablement. However,
we did not extract this data because they did not meet our review
criteria.
Mainous 2000 conducted a four-arm factorial study.We extracted
data for two comparisons that were relevant to this review: written
information compared to usual care; and written information plus
prescribing feedback to clinicians compared to feedback alone. All
interventions were aimed at clinicians.
1. Written information (53 clinicians): Clinicians received
letters about the study ’without information on costs and
profiling’ along with 25 two-page patient education pamphlets
entitled ’Your child and antibiotics’ produced by the Centers for
Disease Control and Prevention (CDC) and the American
Society for Microbiology. Clinicians also received information
about where to access further copies of the CDC pamphlet.
Content of the letter was not defined and fidelity was not
assessed.
2. Prescribing feedback to clinicians (49 clinicians): Study
authors provided clinicians with their antibiotic prescribing
profile for paediatric acute URTIs (common cold), acute
bronchitis, and purulent rhinitis for a period prior to the
intervention. The prescribing profile consisted of total number
of episodes of care for stated paediatric respiratory conditions,
the number and proportion that received antibiotics, the total
cost of the episode, and the proportionate cost of antibiotics in
the cost of evaluation and managing these conditions (as per
Medicaid). Clinicians also received their percentile rank for
antibiotic prescribing compared with their peers.
3. Written information plus prescribing feedback to clinicians
(52 clinicians).
4. Usual care (62 clinicians).
Excluded studies
We excluded 51 full-text studies (Figure 1, Characteristics of
excluded studies). Of these, 17 studies were excluded because
they contained multiple components and the effect of written in-
formation could not be determined. Common co-interventions
included clinician education and training (Altiner 2007; Doyne
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2004; Flottorp 2002; Gonzales 1999; Gonzales 2013; Hickman
2003; Jenkins 2013; Légaré 2011; Metlay 2007; Price 2011;
Ratchina 2011; Rubin 2005; Smabrekke 2002; Smeets 2009;
Trepka 2001; Welschen 2004), clinical champions and leaders
(Gonzales 2013; Metlay 2007; Price 2011), increases in fees for
telephone consultation (Flottorp 2002), decision support aids
and reminders (Flottorp 2002; Gonzales 2013), monitoring, au-
dit and feedback on prescribing (Doyne 2004; Gonzales 2004;
Gonzales 2013;Welschen 2004), and education for non-clinicians
(Welschen 2004).
We excluded 14 studies because they were not RCTs (Adinoff
2006; Agnew 2013; Allaire 2011; Becker 2002; Briel 2010;
Farquhar 2002; Formoso 2011; Hay 2010; Linder 2008; Moore
2010; Rodis 2004; Shaughnessy 2002; Vega 2015; Wright 2002).
Twelve studies did not include data on patients with URTIs
(Bauchner 2001; Everitt 2006; Hallsworth 2016; Kullgren 2016;
Macfarlane 2002; Moore 2009; Olives 2016; Schnellinger 2010;
Sustersic 2012; Taylor 2003; Taylor 2005; Yu 2015). Four of these
studies offered written information to patients presenting to pri-
mary care for any reason (Bauchner 2001; Taylor 2003; Taylor
2005; Schnellinger 2010). We contacted the authors of these four
studies and found that data for URTIs were no longer available
(Bauchner 2001; Schnellinger 2010); or we did not receive re-
sponses (Taylor 2003; Taylor 2005). Two studies recruited patients
with LRTIs (Macfarlane 2002; Moore 2009), and one recruited
patients with infective conjunctivitis (Everitt 2006).
Eight studies did not deliver written information or delivered the
information but not at the time of prescribing. Dolovich 1999,
Gonzales 2005, Teng 2006, and Turnbull 2015 directed the inter-
vention to clinicians; Finkelstein 2001 mailed information to pa-
tients after the consultation; Formoso 2013 used advertisements
in local media; Sahlan 2008 assessed patients’ views; and Segador
2005 provided information stating the importance of completing
an antibiotic course.
We classified one study as awaiting classification (Alder 2005).
This study measured the number of antibiotics prescribed by clin-
icians and parental satisfaction following the delivery of written
information about antibiotics, but they did not report how they
measured this nor did they provide the outcome data. We con-
tacted the study authors to obtain these data, but did not receive a
reply. We will re-contact these authors when updating this review.
Risk of bias in included studies
Risk of bias assessments are summarised below and are described
in detail in the Characteristics of included studies tables.
Allocation
Selection bias varied between studies.We rated Francis 2009 at low
risk of bias because we considered their randomisation and allo-
cation concealment procedures appropriate. We assessedMainous
2000 at high risk of bias because randomisation and concealment
were poorly reported, and baseline differences between groups im-
plied inadequate randomisation.
Blinding
It was not possible to blind clinicians or participants to the inter-
vention in either study (Francis 2009; Mainous 2000). Although
Francis 2009 used blinded telephone assessors, participants self-
reported the subjective outcomes, introducing a high risk of bias.
Mainous 2000 used an objective measure of antibiotic prescribing
by clinicians, indicating a low risk of bias.
Incomplete outcome data
Attrition varied between the included studies. Francis 2009 had a
low risk of bias (< 20%attrition, equal in both groups and analysed
using an intention-to-treat analysis). In contrast, Mainous 2000
had a high risk of bias because 53 clinicians were excluded, but
the study did not report when they were excluded or from which
arm, and intention-to-treat analysis was not conducted.
Selective reporting
The risk of reporting bias varied between the included studies. A
published study protocol (Francis 2008) was available for Francis
2009 and the study was reported as planned. A protocol was not
available for Mainous 2000 and we assessed the risk of bias for
selective reporting as unclear.
Other potential sources of bias
In Mainous 2000, clinicians received 25 pamphlets as part of the
intervention and the study authors did not assess fidelity of dis-
tributing pamphlets to patients or ordering more copies. We as-
sessed the risk of clustering in this study as high because the study
authors randomised clinicians rather than patients, but did not
adjust for this in their analysis. Francis 2009 received an educa-
tional grant to fund the GP training website; however, we rated
this as a low risk of bias as they declared no conflicts of interest
and stated the study was conducted independently of the funder.
Effects of interventions
See: Summary of findings for the main comparison Written
information for patients (or parents of child patients) compared
to usual care; Summary of findings 2 Written information for
patients (or parents of child patients) plus prescribing feedback to
clinicians compared to prescribing feedback alone
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Written information compared to usual care
Primary outcome
1. Antibiotic use: written information significantly reduced
the number of antibiotics used by patients (RR 0.53, 95% CI
0.35 to 0.80; ARR 20% (22% versus 42%); n = 220; Analysis
1.1; Figure 2; Francis 2009). Written information also
significantly reduced the number of antibiotics prescribed by
clinicians in Francis 2009 (RR 0.47, 95% CI 0.28 to 0.78; ARR
21% (20% versus 41%), n = 170) and Mainous 2000 (RR 0.84,
95% CI 0.81 to 0.86; 9% ARR (45% versus 54%), n = 18,643;
Figure 3) (Analysis 1.2). We could not combine these data due to
methodological and statistical heterogeneity (I² statistic = 80%,
P < 0.00001).
Figure 2. Forest plot of comparison: 1 Written information versus control, outcome: 1.1 Antibiotics used by
patients.
Figure 3. Forest plot of comparison: 1 Written information versus usual care, outcome: 1.2 Antibiotics
prescribed by clinicians.
13Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract
infections in primary care (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Secondary outcomes
1. Reconsultation rate: written information had no significant
effect on reconsultation rates (RR 0.79, 95% CI 0.47 to 1.32;
ARR 3% (13% versus 16% reconsulted); n = 347; Analysis 1.3;
Figure 4). Francis 2009 did not reach the predetermined study
threshold for clinical significance of 10% reduction in
reconsultation rates.
Figure 4. Forest plot of comparison: 1 Written information versus usual care, outcome: 1.3 Reconsultation.
1. Resolution of symptoms: neither of the included studies
addressed this outcome.
2. Patient knowledge about antibiotics for acute URTIs:
neither of the included studies addressed this outcome.
3. Patient satisfaction with consultation: written information
had no significant effect on parent satisfaction postconsultation
(RR 0.95, 95% CI 0.87 to 1.03; absolute risk difference 5%
(89% satisfied in written information group compared to 94%
in the usual care group); n =220; Analysis 1.4; Figure 5).
Figure 5. Forest plot of comparison: 1 Written information versus usual care, outcome: 1.4 Patient
satisfaction with consultation.
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1. Complications: neither of the included studies measured
adverse drug reaction due to the prescribed antibiotics or disease
complications, such as pneumonia or mastoiditis.
Written information plus prescribing feedback to
clinicians compared to prescribing feedback alone
Primary outcome
1. Antibiotic use: written information plus feedback
significantly increased the number of antibiotics prescribed by
clinicians (RR 1.13, 95% CI 1.09 to 1.17; absolute risk increase
6% (50% versus 44%); n = 15,149; Analysis 2.1; Figure 6).
Figure 6. Forest plot of comparison: 2 Written information plus prescribing feedback versus prescribing
feedback alone, outcome: 2.1 Antibiotics prescribed by clinicians.
Secondary outcome
Neither study measured reconsultation rate, resolution of symp-
toms, patient knowledge about antibiotics for acute URTIs, pa-
tient satisfaction with consultation or complications for this com-
parison.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Written information for patients (or parents of child patients) plus prescribing feedback compared with prescribing feedback alone to reduce the use of antibiotics for
acute upper respiratory tract infections in primary care
Patient or population: pat ients (or parents of child pat ients) with acute upper respiratory tract infect ions
Settings: primary care
Intervention: writ ten information on ant ibiot ics plus prescribing feedback to clinicians
Comparison: prescribing feedback to clinicians
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Clinician feedback Written information plus
clinician feedback
Antibiot ics prescribed by
clinicians
439 per 1000 496 per 1000
(479 to 514)
RR 1.13 (1.09 to 1.17) 15,149 (1 RCT) ⊕⊕©©
low1,2
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: conf idence interval; RCT : randomised controlled trial; RR: risk rat io.
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1Downgraded due to indirectness. This study Included children with acute URTIs and provided a letter to clinicians. The ef fect
of using writ ten information with adults and delivering it without addit ional a letter to clinicians is not known.
2Downgraded due to risk of bias: high risk of select ion, attrit ion and other bias.
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D I S C U S S I O N
Summary of main results
Compared tousual care,moderate quality evidence fromone study
showed that GPs who provide written information to parents of
children with acute upper respiratory tract infections (URTIs) in
primary care can reduce absolute rates of patient antibiotic use
by 20% and halve the risk of patients using antibiotics, without
any negative impact on reconsultation rates or parental satisfac-
tion (Francis 2009). Low quality evidence from two studies shows
that, compared to usual care, GPs prescribe fewer antibiotics for
acute URTIs but prescribe more antibiotics when written infor-
mation is provided alongside prescribing feedback (compared to
prescribing feedback alone). The effect of written information on
complications, patient knowledge, and resolution of symptoms
has not been investigated.
Overall completeness and applicability of
evidence
The available evidence partly addressed our research question. The
two included studies recruited children and directed the interven-
tion to their parents. We did not identify any eligible studies that
targeted adult patients or that took place in low-income countries.
This limits the generalisability of findings because it is not known
if using written information with these populations would result
in a similar effect.
Both included studies had limitations in delivery of interventions.
Francis 2009 trained GPs to explain the booklet to parents and
elicit parents’ expectations, and Mainous 2000 sent clinicians a
letter with a limited number of patient education (written infor-
mation) pamphlets. The effect of written information about an-
tibiotics provided to patients without any additional interaction
and/or in another format (e.g. electronic) is not known. It is also
not possible to determine from the included studies which are the
most important elements of the written information interventions
used, and which elements, if any, are redundant.
Francis 2009 focused more on patient understanding and be-
haviour, whereas the intervention investigated by Mainous 2000
focused more on prescriber behaviour. Francis 2009 andMainous
2000 measured patient antibiotic use or antibiotics prescribed by
clinicians; in addition, Francis 2009 measured satisfaction and re-
consultation. The effect of written information on complications,
patient knowledge, and resolution of symptoms has not beenmea-
sured. It should be further noted that the uptake of this interven-
tion in different healthcare settings (publicly funded compared
with private, insurance-based systems) may vary.
One study met our criteria for participants, interventions, and
comparators but did not report how they measured our primary
outcome (antibiotic use) nor did they provide the outcome data
(Alder 2005). We contacted the authors to obtain these data but
did not receive a reply. Consequently, we classified the study as
awaiting classification and plan to contact the authors again when
updating this review.
Quality of the evidence
For comparison one (written information compared to usual care),
we graded the evidence asmoderate quality for antibiotic use by pa-
tients, reconsultation, and satisfaction (Francis 2009). We down-
graded these outcomes on risk of bias and indirectness. We as-
sessed Francis 2009 at high risk of performance and detection bias
because unblinded GPs delivered the intervention and unblinded
parents self-reported outcomes (risk of bias). Francis 2009 in-
cluded only children with acute URTIs and trained GPs to deliver
the intervention (indirectness). The effect of this intervention on
adults or when delivered without clinician training or explanation
is not known. We graded the evidence as low quality for antibi-
otic prescribing by clinicians (Francis 2009; Mainous 2000). We
downgraded this assessment based on risk of bias, inconsistency,
indirectness, and precision. We assessed Francis 2009 at high risk
of performance bias and Mainous 2000 at high risk of selection,
attrition, and other bias (providing only 25 pamphlets to the in-
tervention clinicians, which was considered a risk of bias because
clinicians could rapidly run out of the intervention tool with no
clear way of attaining more). We found significant heterogeneity
(inconsistency), studies only included children and their parents,
and provided training or a letter to clinicians (indirectness) and
Francis 2009 had a relatively small sample size with relatively wide
confidence intervals, and we could not adjust for clustering in
Mainous 2000 (precision). Similarly, we graded the quality of the
evidence as low for antibiotic prescribing by clinicians in compari-
son two (written information plus prescribing feedback compared
to feedback alone).
Potential biases in the review process
We employed a robust and comprehensive search strategy to iden-
tify RCTs testing written information compared to no informa-
tion, with no restrictions on language. Two review authors ex-
tracted data and appraised risk of bias. We adjusted for clustering
in our analysis, where possible. For this adjustment, we calculated
ICCs for two outcomes which may have affected our findings
(Francis 2009). We could not adjust the sample size for clustering
in Mainous 2000 because the study authors did not report any
data on cluster size or ICC. Episodes of care could be correlated
in this study because the same parent and child could return to
see their physician on more than one occasion during the data
collection period but these would be counted as separate episodes
of care.
One study met our criteria for participants, interventions, and
comparators but we did not included it in this review because it
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did not report outcome data (Alder 2005). We included Mainous
2000, although study selection criteria included acute bronchitis
(typically classified as a lower respiratory tract infection (LRTI)).
We included this study because most participants included had
acute URTIs (86% for the written information group, 87.1% for
the prescribing feedback to clinicians group, 89.5% for the writ-
ten information plus prescribing feedback to clinicians group, and
85% for usual care group) and the investigators excluded illnesses
that we also set out to exclude fromour review, most notably pneu-
monia. We contacted the study authors to request data excluding
patients with acute bronchitis, but these were unavailable.
We excluded studies that included patients with LRTIs, however,
in clinical practice it is often hard to determine confidently be-
tween a LRTI and URTI. Written information about antibiotics
for LRTIs could also be relevant for the management of URTIs.
We also excluded multicomponent interventions, which greatly
limited the number of studies we could include. However, this
was the most appropriate method to enable us to determine the
effect of written information alone. Another potential bias is the
effect of training clinicians in the use of the written information
intervention. In both included studies, clinicians were given either
formal online training on use of the intervention booklet (Francis
2009), or from an ill-defined letter (Mainous 2000). As such, the
effect of the intervention is unclear and our reported results should
be interpreted as such.
Agreements and disagreements with other
studies or reviews
Five systematic reviews with similar aims have been conducted
(AHRQ 2015; Andrews 2012; Arnold 2005; de Bont 2015;
Vodicka 2013). Findings are broadly in agreementwith this review:
there is limited and conflicting evidence of the benefit of writ-
ten information on antibiotic prescribing for acute URTIs. Two
reviews included both Francis 2009 and Mainous 2000 (AHRQ
2015; Vodicka 2013); two other reviews did not include Mainous
2000, although it met inclusion criteria (Andrews 2012; de Bont
2015); and one review, Arnold 2005, did not include Francis 2009
because it was published after the review.
We identified a number of key differences in inclusion criteria.
AHRQ 2015 and Arnold 2005 reviewed the evidence for any in-
tervention aimed at changing antibiotic prescribing in outpatient
settings. de Bont 2015 reviewed the evidence for patient informa-
tion leaflets in reducing antibiotic use by patients, antibiotic pre-
scribing by clinicians, and reconsultation rates in general practice
for any infection. Vodicka 2013 included randomised and non-
randomised trials of primary care interventions for children with
any respiratory tract infection. Andrews 2012 reviewed the evi-
dence for any intervention influencing antibiotic use and consul-
tation in children with respiratory tract infection delivered at any
point, including prior to the child becoming unwell.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Compared to usual care, moderate quality evidence from Francis
2009 showed that GPs trained to provide written information to
parents of children with acute URTIs in primary care can reduce
patients’ antibiotic use by 20% without any negative impact on
reconsultation rates or parental satisfaction. Primary care clinicians
could implement this intervention by completing the 40 minute
online training and downloading the information resource from
www.whenshouldiworry.com for parents of children with URTIs.
Low quality evidence from two studies shows that, compared to
usual care, GPs prescribe fewer antibiotics for acute URTIs but
prescribe more antibiotics when written information is provided
alongside prescribing feedback (compared to prescribing feedback
alone). There was no evidence addressing resolution of patients’
symptoms, patient knowledge about antibiotics for acute URTIs,
or frequency of complications.
Implications for research
Two very different written information interventions were tested:
one that provided 25 copies of a two-page pamphlet to clinicians
for dissemination to patients and another that used an eight-page
booklet delivered by GPs who had undergone a 40-minute train-
ing session. The written information booklet provided by Francis
2009 has been tested in general practice in the UK. This study
requires replication in other primary care settings globally. Further
RCTs are also needed that test written information in adults with
acute URTIs, in both high- and low-income countries, without
clinician training and that is delivered in different formats (e.g.
electronic), blinds outcome assessors to group allocation, andmea-
sures the effect of written information on antibiotic use by patients
or antibiotic prescribing by clinicians, satisfaction, reconsultation,
knowledge, resolution of symptoms, and complications.
A broader research implication raised by this study is that even
with the 20% absolute reduction in prescribing for acute UR-
TIs demonstrated by Francis 2009, 22% of children with URTIs
still consumed an antibiotic. Given the overwhelming evidence
suggesting antibiotics are not effective in this population (Reveiz
2015; Smith 2014; Spinks 2013; Spurling 2013;Venekamp2015),
ideally few, if any, of these patients should be prescribed antibi-
otics. Therefore, two questions remain prominent: what percent-
age of patients with acute URTIs receiving antibiotics is accept-
able; and can written patient information, either in isolation or
combination with other interventions, achieve this?
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Francis 2009
Methods Cluster-RCT with general practices as the unit of allocation. Authors recruited general
practices from England and Wales via mail and then phone, over an 18-month period
(October 2006 to April 2008). In Wales, general practices were selected randomly; it is
unclear how selection occurred in England. A statistician randomised general practices
by block randomisation and then stratified by list size, antibiotic prescribing rate and
country (Wales, England). Randomised general practices sequentially recruited eligible
patients upon presentation to their practice. South-East Wales Local Research Ethics
committee granted ethics approval
Participants 49 general practices in Wales were randomised, 36 recruited participants. 34 general
practices in England were randomised, 25 recruited participants. Eligible participants
included otherwise well children of any gender, aged between 6 months and 14 years
with acute URTIs (cough, cold, sore throat, earache) for < 7 days. Mean age of recruited
children was five years and they had a mean of three days of symptoms at baseline. The
written information group had slightly fewer males (45%) compared to the usual care
group (54%). General practices in both the written information and the usual care group
had similar median (IQR) list sizes of 6750 (IQR 4400 - 9000) and 6800 (3700 - 8700)
, respectively. Each group had a similar number of practices with above average rates
of prescribing (intervention: 9, control: 10) and a similar number recruiting patients
from England (intervention: 14, control: 11). 274 participants were randomised to the
written information group and 284 to the usual care group
Interventions Parents of children in the intervention group received an eight-page booklet on acute
URTIs in children during a clinical consultation with their GP. The booklet included:
prompts to discuss parent’s concerns and expectations; information on how to manage
a fever; advice about temperature fits (febrile convulsions); information about antibiotic
effectiveness for cough, green phlegm, sore throat, earache and croup; when not to take
antibiotics; and,when further help should be sought. Parents could take the booklet home
following the consultation. GPs received online training on how to use this resource. It
included education on: the content and aims of the booklet; encouraged its use within
the consultation; and, the use of communication skills to explore parental concerns and
expectations. The content of the booklet could not be tailored to individual patients
Outcomes Reconsultation rate was the primary outcome (attending a face-to-face consultation
about the same illness within 2 weeks of the index consultation). Relevant secondary
outcomes included: antibiotics prescribed by clinicians, antibiotics used by patients, and
parental satisfaction
Notes Funded by Medical Research Council, Welsh Assembly Government and Pfizer
Risk of bias
Bias Authors’ judgement Support for judgement
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Francis 2009 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: ’Practices were randomised by a
statistician using block randomisation with
random block sizes and stratification by
practice list size, antibiotic prescribing rate
for 2005, and country.’
Comment: The randomisation technique
was adequate andwell described. The study
statistician created the randomisation ta-
ble using random permuted block sizes.
Groups were comparable at baseline
Quote: ’Participating clinicians were asked
to recruit sequential eligible children (6
months to 14 years) consulting with an up-
per respiratory tract infection (cough, cold,
sore throat, earache for seven days or less)
and their parents.’
Comment: Individual children could not
be randomised as GPs cannot go from a
trained to untrained state. The authors
noted the potential bias in cluster randomi-
sation and put measures in place to identify
any selection bias: they requested GPs to
record non-identifiable data for eligible pa-
tients not recruited. They did not identify
any important differences between those
recruited and those not recruited. There
was also similar recruitment rates between
written information and usual care groups
Allocation concealment (selection bias) Low risk Quote (from Protocol: Francis 2008): ’the
study statistician will create a randomisa-
tion table using random permuted block
sizes. These tables will be kept securely and
allocation for each practice will be provided
only after the practice has agreed to partic-
ipate and the practice ID and stratification
variables are provided to the statistician.’
Comment: Clinicians could not foresee
which group that were allocated to
Comment: Figure 1 from protocol Francis
2008 shows method of patients consenting
prior to delivery of intervention
Comment: Patients and parents did not
know which group they were enrolled in
prior to informed consent
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: ’Neither clinicians nor participants
were blinded as to study group.’
Comment: Neither clinicians nor partici-
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pants were blinded and outcomes were self-
reported and thus, subjective
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Quote: ’Follow-up was via a telephone ad-
ministered questionnaire with the child’s
parent or guardian, 14 days after recruit-
ment.’
Comment: Although telephone interview-
ers were blinded when collecting out-
come data, the outcomes were self-re-
ported. Therefore, the true assessors of out-
comes were the parents themselves, who
were unblinded and reported subjectively
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: ’The primary analysis was intention
to treat.’
Quote: ’We achieved a follow-up rate of 94.
6% (93.4% intervention, 95.8% control)
for the primary outcome data.’
Comment: Attrition was similar in written
information (intervention) and usual care
(control) groups: 11 practices failed to re-
cruit in both groups; no practices were lost
to follow-up; one patient withdrew from
the written information group and two
from the usual care group; 17 were lost to
follow-up in the written information group
and 10 in the usual care group. The authors
used an intention-to-treat analysis
Selective reporting (reporting bias) Low risk Comment: All outcomes were reported as
outlined in the study protocol (Francis
2008)
Other bias Low risk Quote: ’All participating clinicians were
provided with information about the aims
of the study. However, antibiotic use was
listed fourth in a long list of outcome mea-
sures and is therefore unlikely to have re-
sulted in meaningful changes in prescrib-
ing behaviour.’ ’Funding for the develop-
ment of the training website was from an
educational grant from Pfizer UK...All au-
thors declare that this work was conducted
independently of the study funders.’
Comment: Authors acknowledged a poten-
tial Hawthorne effect and mitigated this
by disguising desired outcomes among a
26Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract
infections in primary care (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Francis 2009 (Continued)
long list of study outcomes. Pfizer supplied
funding for the educational website but
report the work was conducted indepen-
dently and do not declare any competing
interests
Mainous 2000
Methods 4-arm factorial randomised control trial usingprimary care clinicians as unit of allocation.
Data from Medicaid was matched with Kentucky Medical Licensure Board (KMLB)
to select primary care clinicians with experience in managing paediatric acute URTIs.
Eligible clinicians that had billed for at least 75 episodes of any combination of the
paediatric acute URTIs (see participants below) and at least 25 URTI episodes between 1
July 1995 and 30 June 1996. Individuals with this level of service were initially included
in the study; however, individuals were kept in the study if they managed at least 5
acute URTIs/purulent rhinitis/acute bronchitis episodes in each of the 3 study periods
of Autumn 1996, Winter/Spring 1997, and Autumn 1997
The intervention period of the study was from 1 July 1997 to 30 November 1997
Participants 269 primary care clinicians who provided primary care in either private or hospital-
based practice and were family physicians (GPs), paediatricians or ’other primary care’.
Otolaryngology specialists were excluded
Patients (and their parents) aged less than 18 years old of any gender who were diagnosed
with any of nonsuppurative otitis media, suppurative otitis media, sinusitis, strepto-
coccal pharyngitis, pharyngitis/tonsillitis, rhinitis, acute URTI (common cold) or acute
bronchitis were included. Patient presentations were measured as ’episodes of care’, al-
lowing multiple presentations for individual patients. A total of 33,792 episodes of care
were reported (8274 (written information), 8946 (prescribing feedback to clinicians),
6203 (written information plus prescribing feedback to clinicians), 10,369 (usual care))
. Baseline differences evident in the number of URTI episodes (written information: 71.
3 +/- 84.2, usual care: 89.5 +/-125.2; written information and prescribing feedback to
clinicians: 44.3 +/- 48.5, prescribing feedback: 70.9 +/- 89.2); and the geographical loca-
tion of the clinicians targeted (written information: 81.1% rural, prescribing feedback to
clinicians: 49.0% rural; written information plus prescribing feedback to clinicians: 76.
9% and usual care: 80.7% rural). Most episodes of care were for the common cold (86%
for written information; 87% for prescribing feedback to clinicians; 90% for written
information plus prescribing feedback to clinicians; and 85% for usual care)
Interventions Selected clinicians (and respective patients) were randomised to one of four groups:
1. Prescribing feedback to clinicians: Clinicians received a copy of their antibiotic pre-
scribing profile for paediatric acute URTI (common cold), acute bronchitis and puru-
lent rhinitis for the period prior to the intervention (1 July 1995 to 30 June 30 1997)
. Prescribing profile consisted of: total number of episodes of care for stated paediatric
respiratory conditions, the number and proportion that received antibiotics, the total
cost of the episode and the proportionate cost of antibiotics in the cost of evaluation
and managing these conditions (as per Medicaid). In addition to the prescribing profile,
clinicians also received their percentile rank for antibiotic prescribing compared to their
peers
2. Written information: Clinicians received 25 x 2-page patient education pamphlets -
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’Your Child and Antibiotics’ - produced by the Centres for Disease Control and Preven-
tion (CDC) and the American Society for Microbiology, along with an accompanying
letter ’without information on costs and profiling. Clinicians could access further pam-
phlets if required. Fidelity to intervention or how pamphlets were given to parents has
not been reported
3. Written information plus prescribing feedback to clinicians: Clinicians (and their
patients, in the patient education arm) received both prescribing feedback and written
information
4. Usual care: no intervention
Outcomes Antibiotic prescribing by clinicians
Notes Funded by Department of Public Health, Commonwealth of Kentucky
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: ’The physicians in the four groups
were randomised.’
Comment: Participants were randomised,
however it is not clear how selected partic-
ipants were randomised
Further, there were differences between
groups at baseline, implying randomisation
attempts were inadequate
Allocation concealment (selection bias) High risk It is not clear if any allocation concealment
was attempted. Further, as the randomisa-
tion methodology was unclear we assumed
this risk of bias to be high
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Any blinding attempts were not reported.
It was not possible to blind clinicians or
participants. Outcomes, however, were ob-
jective, which mitigates need for blinding
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Objective
outcomes, not clear who searched through
Medicaid data and if they were blinded or
not, however objective outcome
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: ’Fifty-three of those physicianswere
excluded from the final analysis because
we could not document that each had five
or more episodes of care for children for
URIs, purulent rhinitis, or acute bronchitis
in each of three study periods.’
Comment: 53 physicians were excluded as
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they did not meet the extended inclusion
criteria, it is not clear at what time point
they were excluded and from which arm
they were excluded from. Further, no in-
tention-to-treat analysis was performed
Selective reporting (reporting bias) Unclear risk Given there was no prior published proto-
col, we cannot determine if other outcomes
were measured and then not reported
Other bias High risk Quote: ’Each physician received 25 pam-
phlets and instructions that additional
pamphlets could be obtained from the
CDC.’
Comment: Fidelity was not assessed.
Quote: ’Prescribing for an illness was at-
tributed to an individual physician. How-
ever, a specific respiratory infection may re-
sult in more than one physician contact.
Therefore, it was necessary to create an
episode of care for any particular respira-
tory infection.’
Comment: Given physicians were ran-
domised and then outcomes assessed via in-
dividual episodes of care, the risk of clus-
tering is high, the authors do not acknowl-
edge this, nor provide adequate data to ad-
just for clustering
IQR: inter-quartile range
URTIs: upper respiratory tract infections
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adinoff 2006 Not RCT
Agnew 2013 Not RCT
Allaire 2011 Not RCT
Altiner 2007 Mutlicomponent intervention
Bauchner 2001 Incorrect patient population
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Becker 2002 Not RCT
Briel 2010 Not RCT
Dolovich 1999 Wrong intervention
Doyne 2004 Multicomponent intervention
Everitt 2006 Incorrect patient population
Farquhar 2002 Not RCT
Finkelstein 2001 Wrong intervention
Flottorp 2002 Multicomponent intervention
Formoso 2011 Not RCT
Formoso 2013 Wrong intervention
Gonzales 1999 Multicomponent intervention
Gonzales 2004 Multicomponent intervention.
Gonzales 2005 Wrong intervention
Gonzales 2013 Multicomponent intervention
Hallsworth 2016 Incorrect patient population
Hay 2010 Not RCT
Hickman 2003 Multicomponent intervention
Jenkins 2013 Multicomponent intervention
Kullgren 2016 Incorrect patient population
Linder 2008 Not RCT
Légaré 2011 Multicomponent intervention
Macfarlane 2002 Incorrect patient population
Metlay 2007 Multicomponent intervention
Moore 2009 Incorrect patient population
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Moore 2010 Not RCT
Olives 2016 Incorrent patient population
Price 2011 Multicomponent intervention
Ratchina 2011 Multicomponent intervention
Rodis 2004 Not RCT
Rubin 2005 Multicomponent intervention
Sahlan 2008 Wrong intervention
Schnellinger 2010 Incorrect patient population
Segador 2005 Wrong intervention
Shaughnessy 2002 Not RCT
Smabrekke 2002 Multicomponent intervention
Smeets 2009 Multicomponent intervention
Sustersic 2012 Incorrect patient population
Taylor 2003 Incorrect patient population
Taylor 2005 Incorrect patient population
Teng 2006 Wrong intervention
Trepka 2001 Multicomponent intervention
Turnbull 2015 Wrong intervention
Vega 2015 Not RCT
Welschen 2004 Multicomponent intervention
Wright 2002 Not RCT
Yu 2015 Incorrect patient population
RCT: randomised controlled trial
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Alder 2005
Methods A four-arm factorial RCT in two suburban primary care clinics in Salt Lake City, Utah. Parents of children presenting
to clinics were the unit of allocation. The randomisation technique was not described and it is unclear how these
primary care clinics were selected. The study period ran from August to December 2000
Participants Recruited 80 (20 per group) parents of children aged 1 to 10 years presenting to the GP with ear pain, sore throat,
cough, congestion and/or fever who had not received antibiotics during the previous two weeks. Age of parents and
age of children were similar between groups, only significant difference at baseline was the number of parents who
were the child’s primary caregiver (difference between groups P = 0.009)
Interventions Parents of child patients were randomised into one of four groups:
1. Communication only intervention: Parents were asked to review and then ask their clinicians four questions.
These questions were adapted from the Talk to your Doctor approach used in the Centres for Disease Control and
Prevention’s (CDC) Use Antibiotics Wisely campaign and were designed to enable parents to obtain necessary
information about the illness affecting their child.
2. Information only intervention: Parents received a pamphlet Antibiotics and Your Child (published by CDC)
and a fact sheet adapted from the Use Antibiotics Wisely campaign. Topics such as ’how bacteria become resistant,
when antibiotics are and are not needed, and following recommended instructions if an antibiotic is prescribed’
were covered in this material.
3. Combined intervention: Parents received both the communication and information intervention.
4. Control arm: Parents received an intervention focused on appropriate nutrition for children. It was not stated
whether this intervention was verbal or written information, but was based on the US Food and Drug
Administration (FDA) TIPS for using the FOOD GUIDE PYRAMID for Young Children 2 to 6 years old
Outcomes Number of antibiotics prescribed by clinicians and parental satisfaction
Notes This study measured the number of antibiotics prescribed by clinicians and parental satisfaction following the delivery
of written information about antibiotics, but they did not report how they measured this nor did they provide the
outcome data. We contacted the study authors to obtain these data, but did not receive a reply. We will re-contact
these authors when updating this review
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D A T A A N D A N A L Y S E S
Comparison 1. Written information versus usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotics used by patients 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2 Antibiotics prescribed by
clinicians
2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3 Reconsultation rates 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
4 Patient satisfaction with
consultation
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Comparison 2. Written information plus prescribing feedback versus prescribing feedback alone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotics prescribed by
clinicians
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Written information versus usual care, Outcome 1 Antibiotics used by patients.
Review: Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
Comparison: 1 Written information versus usual care
Outcome: 1 Antibiotics used by patients
Study or subgroup Intervention Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Francis 2009 (1) 24/108 47/112 0.53 [ 0.35, 0.80 ]
0.02 0.1 1 10 50
Favours written info Favours usual care
(1) with cluster adjustment
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Analysis 1.2. Comparison 1 Written information versus usual care, Outcome 2 Antibiotics prescribed by
clinicians.
Review: Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
Comparison: 1 Written information versus usual care
Outcome: 2 Antibiotics prescribed by clinicians
Study or subgroup Favours written info Usual care Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Francis 2009 (1) 16/84 35/86 0.47 [ 0.28, 0.78 ]
Mainous 2000 3729/8274 5591/10369 0.84 [ 0.81, 0.86 ]
0.01 0.1 1 10 100
Favours written info Favours usual care
(1) with cluster adjustment
Analysis 1.3. Comparison 1 Written information versus usual care, Outcome 3 Reconsultation rates.
Review: Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
Comparison: 1 Written information versus usual care
Outcome: 3 Reconsultation rates
Study or subgroup Intervention Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Francis 2009 (1) 22/170 29/177 0.79 [ 0.47, 1.32 ]
0.2 0.5 1 2 5
Favours written informati Favours usual care
(1) with cluster adjustment
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Analysis 1.4. Comparison 1 Written information versus usual care, Outcome 4 Patient satisfaction with
consultation.
Review: Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
Comparison: 1 Written information versus usual care
Outcome: 4 Patient satisfaction with consultation
Study or subgroup Intervention Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Francis 2009 (1) 96/108 105/112 0.95 [ 0.87, 1.03 ]
0.5 0.7 1 1.5 2
Favours usual care Favours information
(1) with cluster adjustment
Analysis 2.1. Comparison 2 Written information plus prescribing feedback versus prescribing feedback
alone, Outcome 1 Antibiotics prescribed by clinicians.
Review: Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
Comparison: 2 Written information plus prescribing feedback versus prescribing feedback alone
Outcome: 1 Antibiotics prescribed by clinicians
Study or subgroup
Information
plus
feedback Feedback Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Mainous 2000 3079/6203 3929/8946 1.13 [ 1.09, 1.17 ]
0.01 0.1 1 10 100
Written info + feedback Feedback
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid) search strategy
1 exp Respiratory Tract Infections/
2 (respiratory adj3 infection*).tw.
3 (urti or lrti).tw.
4 Otitis Media/
5 otitis media.tw.
6 exp Sinusitis/
7 sinusit*.tw.
8 (acute adj3 (rhinosinusit* or nasosinusit* or rhinit*)).tw.
9 exp Pharyngitis/
10 (pharyngit* or nasopharyngit* or tonsillit*).tw.
11 sore throat*.tw.
12 exp Laryngitis/
13 laryngit*.tw.
14 croup.tw.
15 Cough/
16 cough*.tw.
17 Common Cold/
18 common cold*.tw.
19 coryza.tw.
20 Influenza, Human/
21 (influenza* or flu).tw.
22 Bronchitis/
23 bronchit*.tw.
24 exp Bronchiolitis/
25 bronchiolit*.tw.
26 or/1-25
27 exp Anti-Bacterial Agents/
28 antibiotic*.tw,nm.
29 27 or 28
30 Patient Education as Topic/
31 Pamphlets/
32 (pamphlet* or brochure* or leaflet* or booklet*).tw.
33 (flyer* or flier*).tw.
34 information pack*.tw.
35 information sheet*.tw.
36 (cards or postcard*).tw.
37 (handout* or guidebook*).tw.
38 (print* adj2 (material* or information* or guide or guides or instruction* or advice or advis*)).tw.
39 or/30-38
40 26 and 29 and 39
36Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract
infections in primary care (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Appendix 2. EMBASE (Elsevier) search strategy
#51 #42 AND #50
#50 #45 NOT #49
#49 #46 NOT #48
#48 #46 AND #47
#47 ’human’/de
#46 ’animal’/de OR ’nonhuman’/de OR ’animal experiment’/de
#45 #43 OR #44
#44 random*:ab,ti OR placebo*:ab,ti OR crossover*:ab,ti OR ’cross over’:ab,ti OR trial:ti OR allocat*:ab,ti OR (doubl* NEXT/1
blind*):ab,ti
#43 ’randomized controlled trial’/exp OR ’single blind procedure’/exp OR ’double blind procedure’/exp OR ’crossover procedure’/exp
#42 #24 AND #27 AND #41
#41 #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40
#40 ’health literacy’/de
#39 ’consumer health information’/de
#38 ’information dissemination’/de
#37 ’persuasive communication’/de
#36 (patient* NEAR/3 (literatur* OR material* OR information* OR guide* OR guides OR instruction*)):ab,ti
#35 ((print* OR written OR text*) NEAR/3 (material* OR information* OR guide OR guides OR instruction* OR advice OR advis*
OR messag* OR note OR notes)):ab,ti
#34 handout*:ab,ti OR guidebook*:ab,ti
#33 card:ab,ti OR cards:ab,ti OR postcard*:ab,ti
#32 (information NEAR/2 (pack* OR sheet*)):ab,ti
#31 flyer*:ab,ti OR flier*:ab,ti
#30 pamphlet*:ab,ti OR brochure*:ab,ti OR leaflet*:ab,ti OR booklet*:ab,ti
#29 ’publication’/de
#28 ’patient education’/de
#27 #25 OR #26
#26 antibiotic*:ab,ti
#25 ’antibiotic agent’/exp
#24 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR
#17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23
#23 bronchit*:ab,ti OR bronchiolit*:ab,ti
#22 ’bronchitis’/exp
#21 influenza*:ab,ti OR flu:ab,ti
#20 ’influenza’/exp
#19 coryza:ab,ti
#18 ’common cold’/de OR ’common cold symptom’/de
#17 cough*:ab,ti
#16 ’coughing’/de
#15 croup:ab,ti
#14 ((throat* OR ’middle ear’ OR tonsil* OR sinus* OR laryn* OR pharyn* OR bronch*) NEAR/3 (inflam* OR infect*)):ab,ti
#13 laryngit*:ab,ti
#12 ’laryngitis’/de
#11 ’sore throat’/de
#10 pharyngit*:ab,ti OR nasopharyngit*:ab,ti OR rhinopharyngit*:ab,ti OR tonsillit*:ab,ti
#9 ’pharyngitis’/exp
#8 (acute NEAR/3 (rhinosinusit* OR nasosinusit* OR rhinit*)):ab,ti
#7 sinusit*:ab,ti
#6 ’sinusitis’/exp
#5 ’otitis media’:ab,ti
#4 ’otitis media’/exp
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#3 urti:ab,ti OR lrti:ab,ti
#2 (respiratory NEAR/3 infection*):ab,ti
#1 ’respiratory tract infection’/exp
Appendix 3. CINAHL (Ebsco) search strategy
S52 S42 and S51 S
S51 S43 or S44 or S45 or S46 or S47 or S48 or S49 or S50
S50 (MH “Quantitative Studies”)
S49 TI placebo* OR AB placebo*
S48 (MH “Placebos”)
S47 TI random* OR AB random*
S46 TI ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*)) OR AB ((singl* or doubl* or tripl* or trebl*)W1 (blind* or mask*))
S45 TI clinic* trial* OR AB clinic* trial*
S44 PT clinical trial
S43 (MH “Clinical Trials+”)
S42 S25 and S28 and S41
S41 S29 or S30 or S31 or S32 or S33 or S34 or S35 or S36 or S37 or S38 or S39 or S40
S40 (MH “Information Literacy”)
S39 (MH “Communication”)
S38 (MH “Consumer Health Information”)
S37 TI (patient* N3 (literatur* or material* or information* or guide or guides or instruction*)) OR AB (patient* N3 (literatur* or
material* or information* or guide or guides or instruction*))
S36 TI ((print* or written or text*) N3 (material* or information* or guide or guides or instruction* or advice or advis* or messag* or
note or notes)) OR AB ((print* or written or text*) N3 (material* or
information* or guide or guides or instruction* or advice or advis* or messag* or note or notes))
S35 TI (handout* or guidebook*) OR AB (handout* or guidebook*)
S34 TI (card or cards or postcard*) OR AB (card or cards or postcard*)
S33 TI (information N2 (pack* or sheet*)) OR AB (information N2 (pack* or sheet*))
S32 TI (flyer* or flier*) OR AB (flyer* or flier*)
S31 TI (pamphlet* or brochur* or leaflet* or booklet*) OR AB (pamphlet* or brochur* or leaflet* or booklet*)
S30 (MH “Pamphlets”)
S29 (MH “Patient Education”)
S27 TI antibiotic* OR AB antibiotic*
S26 (MH “Antibiotics+”)
S25 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or
S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23 or S24
S24 TI (bronchit* or bronchiolit*) OR AB (bronchit* or bronchiolit*)
S23 (MH “Bronchitis+”)
S22 TI (influenza* or flu) OR AB (influenza* or flu)
S21 (MH “Influenza+”)
S20 TI coryza OR AB coryza
S19 TI common cold* OR AB common cold*
S18 (MH “Common Cold”)
S17 TI cough* OR AB cough*
S16 (MH “Cough”)
S15 TI croup OR AB croup
S14 TI ((throat* or middle ear* or tonsil* or sinus* or laryn* or pharyn* or bronch*) N3 (inflam* or infect*)) OR AB ((throat* or
middle ear* or tonsil* or sinus* or laryn* or pharyn* or bronch*) N3 (inflam* or infect*))
S13 TI laryngit* OR AB laryngit*
S12 (MH “Laryngitis+”)
S11 TI sore throat* OR AB sore throat*
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S10 TI ((pharyngit* or nasopharyngit* or rhinopharyngit* or tonsillit*)) OR AB ((pharyngit* or nasopharyngit* or rhinopharyngit*
or tonsillit*))
S9 (MH “Pharyngitis”)
S8 TI (acute N3 (rhinosinusit* or nasosinusit* or rhinit*)) OR AB (acute N3 (rhinosinusit* or nasosinusit* or rhinit*))
S7 TI sinusit* OR AB sinusit*
S6 (MH “Sinusitis+”)
S5 TI otitis media OR AB otitis media
S4 (MH “Otitis Media+”)
S3 TI ( urti or lrti ) OR AB ( urti or lrti )
S2 TI respiratory N3 infection* OR AB respiratory N3 infection*
S1 (MH “Respiratory Tract Infections+”)
Appendix 4. LILACS (BIREME) search strategy
(MH:“Anti-Bacterial Agents” OR Antibacterianos OR Antibacterianos OR antibiotic$ ORMH:D27.505.954.122.085$ OR Antibac-
terianos OR Antibióticos) AND (MH:“Patient Education as Topic” OR “Educación del Paciente” OR “Educação de Pacientes” OR
Pamphlets OR Folletos OR Folhetos OR Panfletos OR Libretes OR Livretos OR booklet$ OR brochur$ OR flyer$ OR flier$ OR
card OR cards OR postcard$ OR handout$ OR guidebook$ OR MH:“Consumer Health Information” OR “Información de Salud
al Consumidor” OR “Informação de Saúde ao Consumidor” OR MH:I02.233.332.186$ OR MH:N02.421.143.827.407.228$ OR
N02.421.726.407.228$ OR MH:“Persuasive Communication” OR “Comunicación Persuasiva” OR “Comunicação Persuasiva” OR
MH:“Information Dissemination” OR “Diseminación de Información” OR “Disseminação de Informação” OR “information sheet”
OR “information sheets” OR “information pack” OR “information packs” OR “information package” OR “printed information” OR
“printed instructions” OR “printed guides” OR “patient information” OR “patient instructions”)
Appendix 5. Web of Science (Thomson Reuters) search strategy
# 6 #5 AND #4
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 5 TOPIC: (random* or placebo* or ((singl* or doubl*) NEAR/1 blind*) or crossover* or “cross-over” or allocat*) OR TITLE:
(trial)
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 4 #3 AND #2 AND #1
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 3 TOPIC: (pamphlet* or brochur* or leaflet* or booklet* or flyer* or flier* or (information NEAR/3 (pack* or sheet*)) or card
or cards or postcard* or handout* or guidebook* or ((print* or written or text*) NEAR/3 (material* or information* or guide
or guides or instruction* or advice or advis* or messag* or note or notes)) or ((patient* or consumer*) NEAR/3 (literatur* or
material* or information* or guide or guides or instruction*)))
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 2 TOPIC: (antibiotic* or anti-bacterial*)
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
# 1 TOPIC: ((respiratory NEAR/3 infection*) or urti or lrti or “otitis media” or sinusit* or (acute NEAR/1 (rhinosinusit* or
nasosinusit* or rhinit*)) or pharyngit* or nasopharyngit* or rhinopharyngit* or tonsillit* or “sore throat” or “sore throats” or
laryngit* or ((throat* or “middle ear” or tonsil* or sinus* or laryn* or pharyn* or bronch*) NEAR/3 (infect* or inflam*)) or
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(Continued)
croup or cough* or “common cold” or “common colds” or coryza or influenza* or flu or bronchit* or bronchiolit*)
Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, CCR-EXPANDED, IC Timespan=All years
Appendix 6. WHO International Clinical Trials Registry Platform Search Portal
Searched: ’information AND upper respiratory tract infections AND patient AND antibiotics’
Appendix 7. clinicaltrials.gov
Searched: ’information AND upper respiratory tract infections AND patient AND antibiotics
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Amanda McCullough has been changed to last author. Paul Glasziou has been changed to third author. The title of this review has been
changed to: Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory
tract infections in primary care. The following sentence was deleted from the ’Methods, Types of studies’ section, because inclusion
of these studies would not enable the effect of written information to be determined: “We will also include studies that compared
information and another intervention with a control (for example, usual care).” We also changed the following sentence from: ’Trials
that include information as the only intervention and those that include information as an add-on intervention will be included.’ to ‘We
also included studies that included information as an add-on intervention.’ Primary care was not defined in the protocol; a definition
is included in the review. See Types of participants. GRADE methods were not mentioned in the protocol, but have been used in this
review.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Acute Disease; Anti-Bacterial Agents [∗therapeutic use]; General Practice; Inappropriate Prescribing [∗prevention & control; statistics
& numerical data]; Pamphlets; Parents; Patient Education as Topic [methods]; Randomized Controlled Trials as Topic; Respiratory
Tract Infections [∗drug therapy; virology]; Virus Diseases [drug therapy]
MeSH check words
Child; Humans
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